Avenue therapeutics announces last patient last visit in phase 1b/2a clinical trial of aj201 for the treatment of spinal and bulbar muscular atrophy (kennedy's disease)

Topline results of the phase 1b/2a clinical trial anticipated mid-year 2024 topline results of the phase 1b/2a clinical trial anticipated mid-year 2024

ATXI Ratings Summary

ATXI Quant Ranking